QUSVM
KRRO icon

Qiming U.S. Ventures Management’s Korro Bio KRRO Stock Holding History

Qiming U.S. Ventures Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17.6M Hold
368,085
– – 31.68% 2
2025
Q2 		$4.6M Hold
368,085
– – 19.47% 3
2025
Q1 		$6.41M Hold
368,085
– – 27.74% 2
2024
Q4 		$14M Hold
368,085
– – 27.4% 3
2024
Q3 		$12.3M Hold
368,085
– – 23.95% 3
2024
Q2 		$12.5M Hold
368,085
– – 23.69% 2
2024
Q1 		$33.1M Hold
368,085
– – 36.93% 1
2023
Q4 		$17.6M Buy
+368,085
New +$12.1M 16.15% 2

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Qiming U.S. Ventures Management's KRRO Position: Q3 2025 in Review

Qiming U.S. Ventures Management held its Korro Bio (KRRO) position steady in Q3 2025 at 368,085 shares worth $17.6M. The position accounts for 31.68% of the portfolio, ranked #2.

Qiming U.S. Ventures Management first reported a position in KRRO in Q4 2023 and has held it in 8 quarters since. The position peaked at $33.1M in Q1 2024. 92 funds tracked by Wall St. Rank hold KRRO as of Q3 2025.

  • Qiming U.S. Ventures Management held 368,085 shares of Korro Bio worth $17.6M as of Q3 2025.
  • Qiming U.S. Ventures Management left its Korro Bio share count unchanged in Q3 2025.
  • Korro Bio made up 31.68% of Qiming U.S. Ventures Management's portfolio in Q3 2025, its #2 holding.
  • Qiming U.S. Ventures Management first reported a position in Korro Bio in Q4 2023 and has held it in 8 quarters since.
  • Qiming U.S. Ventures Management's Korro Bio position peaked at $33.1M in Q1 2024.
  • 92 funds tracked by Wall St. Rank held Korro Bio as of Q3 2025.

Based on Qiming U.S. Ventures Management's 13F filing for Q3 2025, filed 10 Nov 2025.